President Trump Pauses Implementation of Tariffs for One Month

Published in Government Relations on February 04, 2025

On Monday, Feb. 3, President Donald Trump suspended his threat of imposing 25% tariffs on Mexico and Canada at the last minute, agreeing to a one-month pause in exchange for concessions on border security and crime enforcement. 

The proposed tariffs, announced by Trump on Saturday, included a 25% duty on all imports from Mexico and most imports from Canada, with a carve-out for a 10% tariff on energy products. Additionally, a new 10% tariff on Chinese goods was proposed. Trump mentioned earlier on Monday that he would be speaking with China soon. 

VGM Government Relations will provide updates as more information becomes available. 

Impact Of Tariffs On The DMEPOS Industry 

Published in Government Relations on Jan. 31, 2025 

President Donald Trump announced on Thursday that he will impose 25 percent tariffs on Canada and Mexico starting Saturday, Feb. 1. The durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry is closely monitoring the situation to see what, if any, exclusions might be included for medical equipment and products. An increase in tariffs could lead to several key impacts: 

  1. Increased Wholesale Costs: The cost of importing medical equipment from overseas will rise, impacting the overall expenses for DMEPOS providers. This increase in costs is likely to be passed on to consumers, leading to higher prices for medical devices and supplies. For instance, tariffs on Chinese-made medical devices could increase prices by up to 25%, affecting a wide range of products from syringes to diagnostic equipment. 
     
  2. Access To Medical Equipment: Higher costs may limit the availability of essential medical devices, making it harder for providers to maintain adequate supplies. This could particularly impact smaller providers who may struggle to absorb the increased costs. The tariffs could also lead to shortages of critical medical supplies, as providers may reduce their orders to manage costs. 
     
  3. Timely Delivery: The tariffs could exacerbate delays in the supply chain, similar to the disruptions experienced during the supply chain shortage in 2023. The previous shipping crisis had a significant impact on the access and cost of DMEPOS, causing delays and increased expenses. Similar challenges are anticipated with the new tariffs, as increased costs and potential retaliatory measures from affected countries could further disrupt the supply chain. 

What Can You Do Now? 

Providers may face increased financial pressure, which could affect their ability to deliver timely and affordable care to patients. The industry must prepare for these potential disruptions by: 

  • Exploring Alternative Supply Sources: Identify and establish relationships with new suppliers who are not affected by the tariffs. 
     
  • Increasing Inventory Levels: Stockpile essential medical supplies to buffer against potential shortages and delays. 
     
  • Advocating For Policy Changes: Engage with policymakers to advocate for measures that mitigate the impact of tariffs on essential medical supplies. 

VGM Government Relations will keep you updated as we learn more about this. 

From Our Experts

Join HME Industry Letter on CB Program to CMS Administrator Oz thumbnail Join HME Industry Letter on CB Program to CMS Administrator Oz HME suppliers, manufacturers, and distributors are invited to add their company's name to a letter to CMS Administrator Dr. Mehmet Oz regarding the Administration's DMEPOS/Home Health Proposed Rule that includes provisions for a new competitive bidding round. The letter specifically asks CMS to withdraw or delay the DMEPOS provisions in the Proposed Rule and re-engage with industry, patient, and clinical stakeholders to design an evidence-based, fraud-resistant, America-First framework. Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program thumbnail Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program Now is the time to raise our voices. With the formal announcement of the Competitive Bidding (CB) Program expected as early as the end of this month, we must act swiftly and decisively. Below are two key opportunities to engage with your U.S. Representative and encourage their support for a Congressional letter urging Centers for Medicare & Medicaid Services (CMS) to pause and reassess the CB Program. Legislative Momentum in the HME Industry: Key Updates & Action Items thumbnail Legislative Momentum in the HME Industry: Key Updates & Action Items The past few months have seen a surge of legislative activity in the home medical equipment sector, with several key developments shaping policy and advocacy efforts across the industry. From new bills introduced in Congress to formal comment submissions and stakeholder mobilization, these events reflect growing momentum around critical issues affecting providers and patients alike. This article offers a comprehensive recap of recent actions and outlines important next steps for those... VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports thumbnail VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports VGM has submitted formal comments to the U.S. Department of Commerce in response to its Section 232 National Security Investigation into the importation of personal protective equipment (PPE), medical consumables, and medical equipment and devices. Senate Backs DME Relief Act with Bipartisan Support thumbnail Senate Backs DME Relief Act with Bipartisan Support In a significant development for the durable medical equipment (DME) industry and Medicare beneficiaries, the U.S. Senate has introduced S.2951, the companion legislation to H.R. 2005, known as the DMEPOS Relief Act of 2025. The Senate bill is being led by Senator James Lankford (R-OK) and has gained bipartisan support with Senator Maggie Hassan (D-NH) joining as a co-sponsor. Gov't Shutdown: What It Means for Providers thumbnail Gov't Shutdown: What It Means for Providers As expected, Democrats and Republican members of the Senate was unable to agree on terms in passing a continuing resolution (CR) ahead of the October 1st deadline, resulting in a government shutdown. But how did we get here? Oppose DMEPOS Bidding Expansion – Take Action Now thumbnail Oppose DMEPOS Bidding Expansion – Take Action Now A critical Congressional Sign-On Letter is now circulating in the House of Representatives, led by Reps. Neal Dunn (R-FL) and Greg Murphy (R-NC). This bipartisan letter calls on CMS to stop the proposed expansion of the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) Competitive Bidding Program to include ostomy and urological supplies. Gov't Shutdown & Telehealth Flexibility Expiration thumbnail Gov't Shutdown & Telehealth Flexibility Expiration September 30 represents an important date for HME providers for two reasons: 1) The potential of a government shutdown and how that affects HHS and CMS, and 2) the expiration of Telehealth Flexibilities unless a Continuing Resolution (CR) is agreed upon in time.